Nycomed Gains Rights to NPS’ Gattex™
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 89 (Table of Contents)
Published: 7 Nov-2007
DOI: 10.3833/pdr.v2007.i89.264 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
NPS Pharmaceuticals has licensed the development and commercialization rights to Nycomed for Gattex™ (teduglutide) used in the treatment of gastrointestinal disorders...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS